HSBC Holdings
DGX icon

HSBC Holdings’s Quest Diagnostics DGX Stock Holding History

HSBC Holdings’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-55,000
Closed -$4.58M – 2737
2018
Q4 		$4.58M Hold
55,000
– – 0.01% 1138
2018
Q3 		$5.93M Hold
55,000
– – 0.01% 1054
2018
Q2 		$6.05M Buy
+55,000
New +$5.73M 0.01% 1029

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

HSBC Holdings's DGX Position: Q1 2026 in Review

HSBC Holdings reduced its Quest Diagnostics (DGX) stake by 14% in Q1 2026, selling an estimated $6.21M and leaving 195,144 shares worth $38.2M. The position accounts for 0.02% of the portfolio, ranked #584.

HSBC Holdings first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $96M in Q4 2022. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • HSBC Holdings held 195,144 shares of Quest Diagnostics worth $38.2M as of Q1 2026.
  • HSBC Holdings sold 31,963 Quest Diagnostics shares in Q1 2026, an estimated $6.21M.
  • Quest Diagnostics made up 0.02% of HSBC Holdings's portfolio in Q1 2026, its #584 holding.
  • HSBC Holdings first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • HSBC Holdings's Quest Diagnostics position peaked at $96M in Q4 2022.
  • 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.